Hospital
Greene Memorial Hospital INC
Greene Memorial Hospital INC was paid $11.31M by Medicaid between Jan 2018 and Dec 2024, across 165 billing codes. Its largest line is 99283, emergency room visit (moderate) — 21% of everything it billed.
33Billing provider infoGREENE MEMORIAL HOSPITAL INC
XENIA, OH 45385
XENIA, OH 45385
33aNPI1255317848assigned 12/16/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.31M
24GClaims236,690
24DCodes billed165
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Ohio
Rank by total paid#72 of 101
Median peer was paid$22.32M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official KO, TIMOTHY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 23,531 | $830K | |
| 2019 | 21,634 | $845K | |
| 2020 | 16,700 | $1.00M | |
| 2021 | 18,687 | $1.06M | |
| 2022 | 17,819 | $958K | |
| 2023 | 78,150 | $3.60M | |
| 2024incomplete | 60,169 | $3.01M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 19,383 | 17,843 | $2.36M |
| 96361 | Intravenous infusion, hydration; each additional hour | 16% | 5,652 | 4,366 | $1.81M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 12,849 | 11,651 | $1.80M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.9% | 5,509 | 4,768 | $778K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.0% | 1,847 | 1,530 | $457K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.4% | 4,616 | 3,566 | $390K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.9% | 1,221 | 959 | $333K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.9% | 1,260 | 1,055 | $325K |
| 29581 | 2.6% | 2,877 | 964 | $291K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 3,013 | 988 | $228K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.9% | 1,598 | 1,454 | $218K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 1,448 | 1,124 | $171K |
153 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.5% | 719 | $166K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 1.4% | 197 | $160K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1.2% | 928 | $134K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 1.0% | 1,247 | $118K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.0% | 842 | $116K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.0% | 996 | $114K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 298 | $85K |
| G0378 | Hospital observation service, per hour | <1% | 1,306 | $84K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 14,573 | $83K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,225 | $75K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,641 | $70K |
| 80053 | Comprehensive metabolic panel | <1% | 5,850 | $64K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 518 | $58K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 369 | $50K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,209 | $41K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 255 | $41K |
| 97162 | <1% | 615 | $37K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,618 | $33K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 264 | $30K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 592 | $30K |
| 71250 | <1% | 379 | $29K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,015 | $27K |
| 87529 | <1% | 1,689 | $25K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 21,852 | $23K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 135 | $21K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,445 | $20K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,048 | $19K |
| 73630 | <1% | 700 | $19K | |
| 80061 | Lipid panel | <1% | 1,403 | $17K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,489 | $16K |
| 71045 | Radiologic examination, chest; single view | <1% | 5,341 | $14K |
| 72131 | <1% | 266 | $14K | |
| 82805 | <1% | 697 | $14K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 669 | $13K |
| 84484 | <1% | 6,200 | $13K | |
| 73030 | <1% | 564 | $13K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,047 | $13K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 1,058 | $12K |
| 73562 | <1% | 268 | $12K | |
| 87070 | <1% | 647 | $11K | |
| 73130 | <1% | 434 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 325 | $9K |
| 84439 | <1% | 486 | $9K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,578 | $9K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 98 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 605 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,406 | $8K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 670 | $8K |
| 73610 | <1% | 474 | $7K | |
| 97166 | <1% | 105 | $7K | |
| 72100 | <1% | 153 | $6K | |
| 80076 | <1% | 4,195 | $6K | |
| 84702 | <1% | 340 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 154 | $5K |
| 86780 | <1% | 201 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,924 | $4K |
| 97161 | <1% | 57 | $4K | |
| 80069 | <1% | 455 | $4K | |
| 87186 | <1% | 783 | $4K | |
| 73502 | <1% | 133 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 5,466 | $3K |
| 73110 | <1% | 205 | $3K | |
| 83735 | <1% | 1,555 | $3K | |
| 76830 | Ultrasound, transvaginal | <1% | 77 | $3K |
| 81001 | <1% | 7,521 | $3K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 12 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,586 | $3K |
| 82607 | <1% | 116 | $3K | |
| 86803 | <1% | 101 | $3K | |
| 70496 | <1% | 16 | $2K | |
| 74018 | <1% | 55 | $2K | |
| 85027 | <1% | 613 | $2K | |
| 90715 | <1% | 128 | $2K | |
| 96367 | <1% | 125 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,249 | $2K |
| 82043 | <1% | 242 | $2K | |
| 86705 | <1% | 39 | $2K | |
| 82728 | <1% | 94 | $2K | |
| 85610 | <1% | 763 | $2K | |
| 87077 | <1% | 561 | $2K | |
| 83540 | <1% | 145 | $2K | |
| 80074 | <1% | 44 | $1K | |
| 83690 | <1% | 4,775 | $1K | |
| 93971 | <1% | 13 | $1K | |
| 96376 | <1% | 1,001 | $1K | |
| 70486 | <1% | 42 | $1K | |
| 73560 | <1% | 170 | $1K | |
| 86709 | <1% | 52 | $1K | |
| 92523 | <1% | 12 | $1K | |
| 86706 | <1% | 40 | $1K | |
| 86708 | <1% | 40 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 117 | $945.43 |
| 81003 | <1% | 1,591 | $887.45 | |
| 83880 | <1% | 572 | $880.38 | |
| 83550 | <1% | 112 | $853.66 | |
| 87340 | <1% | 54 | $820.55 | |
| 83970 | <1% | 26 | $801.01 | |
| 81025 | <1% | 2,884 | $708.97 | |
| 85651 | <1% | 251 | $673.50 | |
| 82746 | <1% | 74 | $618.17 | |
| 87634 | <1% | 122 | $467.09 | |
| 82570 | <1% | 44 | $438.79 | |
| 85378 | <1% | 689 | $384.22 | |
| 85007 | <1% | 300 | $377.66 | |
| 87040 | <1% | 1,050 | $377.23 | |
| 84145 | <1% | 825 | $365.84 | |
| 83605 | <1% | 1,315 | $363.09 | |
| 84450 | <1% | 17 | $309.12 | |
| J3490 | Unclassified drugs | <1% | 716 | $305.35 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 188 | $250.98 |
| 73140 | <1% | 13 | $242.07 | |
| 84550 | <1% | 26 | $211.87 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 346 | $206.13 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 74 | $181.54 |
| 84460 | <1% | 17 | $164.31 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 150 | $159.03 |
| 87210 | <1% | 153 | $158.49 | |
| 85014 | <1% | 14 | $137.78 | |
| 82550 | <1% | 137 | $131.79 | |
| 73080 | <1% | 15 | $128.51 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 774 | $108.87 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,713 | $103.85 |
| 29125 | <1% | 33 | $83.35 | |
| 84100 | <1% | 60 | $71.68 | |
| 85018 | <1% | 14 | $62.63 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 100 | $45.84 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,939 | $43.92 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 560 | $37.61 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,001 | $37.15 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 281 | $34.75 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 589 | $24.91 |
| 85730 | <1% | 64 | $18.77 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 27 | $18.74 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 79 | $18.12 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 459 | $14.69 |
| 81015 | <1% | 91 | $10.32 | |
| J1790 | Injection, droperidol, up to 5 mg | <1% | 195 | $9.08 |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 15 | $8.51 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 227 | $6.76 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 115 | $5.64 |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 47 | $4.82 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 225 | $2.32 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 23 | $1.89 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 62 | $1.66 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 50 | $0.38 |
| J2471 | Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg | <1% | 37 | $0.26 |
| 94760 | 0% | 26 | $0.00 | |
| 84703 | 0% | 29 | $0.00 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 0% | 24 | $0.00 |
| 72128 | 0% | 16 | $0.00 | |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 13 | $0.00 |
| 70498 | 0% | 16 | $0.00 | |
| 82010 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKO, TIMOTHY (KETTERING HEALTH CFO)
| Provider | Location | Paid |
|---|---|---|
| Dayton Osteopathic Hospital | Dayton, OH | $111.27M |
| Alliance Physicians INC | Kettering, OH | $38.76M |
| Kettering Medical Center | Kettering, OH | $37.96M |
| Beavercreek Medical Center | Beavercreek, OH | $30.49M |
| The Fort Hamilton Hospital | Hamilton, OH | $27.06M |
| Kettering Medical Center | Miamisburg, OH | $20.00M |
| Kettering Medical Center | Troy, OH | $10.83M |
| Kettering Independent Medical Group INC | Miamisburg, OH | $8.39M |
| Kettering Affiliated Health Services | Miamisburg, OH | $2.12M |
| Greene Memorial Hospital, INC. | Jamestown, OH | $1.53M |
| Alliance Physicians INC | Moraine, OH | $1.42M |
| Alliance Physicians INC | Huber Heights, OH | $1.06M |
| Greene Memorial Hospital INC | Yellow Springs, OH | $843K |
| Alliance Physicians INC | Miamisburg, OH | $744K |
| Greene Memorial Hospital INC | Cedarville, OH | $703K |
| Alliance Physicians INC | Xenia, OH | $645K |
| Alliance Physicians INC | Springboro, OH | $616K |
| Alliance Physicians INC | Kettering, OH | $599K |
| Sycamore Primary Care Group | Miamisburg, OH | $564K |
| Alliance Physicians INC | Beavercreek, OH | $486K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.